Akero Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Akero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akero Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akero Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $943k | 40k | 23.35 |
| 2023-09-30 | $2.2M | 43k | 50.58 |
| 2023-06-30 | $2.4M | 51k | 46.69 |
| 2023-03-31 | $1.1M | 28k | 38.26 |
| 2022-12-31 | $1.5M | 27k | 54.80 |
| 2022-09-30 | $440k | 13k | 33.93 |
| 2022-06-30 | $122k | 13k | 9.52 |
| 2022-03-31 | $154k | 11k | 13.81 |
| 2021-12-31 | $234k | 11k | 21.57 |
| 2021-09-30 | $683k | 31k | 22.34 |
| 2021-06-30 | $256k | 10k | 24.77 |
| 2021-03-31 | $561k | 11k | 50.00 |
| 2020-12-31 | $745k | 29k | 26.12 |
| 2020-09-30 | $304k | 9.9k | 30.76 |